# DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC

> **NCT06354231** · PHASE2 · RECRUITING · sponsor: **Fudan University** · enrollment: 20 (estimated)

## Conditions studied

- Renal Insufficiency
- Upper Urinary Tract Urothelial Carcinoma
- Solitary Kidney

## Interventions

- **DRUG:** DV
- **DRUG:** Toripalimab
- **PROCEDURE:** Laser surgery

## Key facts

- **NCT ID:** NCT06354231
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-20
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06354231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06354231, "DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06354231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*